Chinese Healthcare System
Cross-source consensus on Chinese Healthcare System from 1 sources and 4 claims.
1 sources · 4 claims
Uses
How it works
Background
Evidence quality
Highlighted claims
- Over 96% of patients in both cohorts had at least one specialist visit during baseline, while only approximately 25% had any GP visit — a pattern that persisted into follow-up. — Clinical characteristics and outcomes of patients with type 2 diabetes mellitus and chronic kidney disease from two new-user medication cohorts: a retrospective cohort study using regional electronic health records database in China
- Laboratory monitoring coverage was incomplete: only approximately 50% of patients with a baseline eGFR or serum potassium measurement had at least one repeat measurement during follow-up, with UACR coverage consistently low. — Clinical characteristics and outcomes of patients with type 2 diabetes mellitus and chronic kidney disease from two new-user medication cohorts: a retrospective cohort study using regional electronic health records database in China
- The predominance of specialist over GP visits reflects a structural feature of Chinese healthcare during the study period, not individual patient behaviour. — Clinical characteristics and outcomes of patients with type 2 diabetes mellitus and chronic kidney disease from two new-user medication cohorts: a retrospective cohort study using regional electronic health records database in China
- Despite national guidance in 2015 and Tianjin's own 2017 plan both aiming to shift chronic disease management toward primary care, EHR data suggest this transition had not yet occurred during the study period. — Clinical characteristics and outcomes of patients with type 2 diabetes mellitus and chronic kidney disease from two new-user medication cohorts: a retrospective cohort study using regional electronic health records database in China